ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today that the European Medicines Agency has recommended granting a conditional marketing ...
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM ...
– ER-positive breast cancer accounts for approximately 70% of breast cancer cases, and up to a third experience recurrence on or after adjuvant endocrine therapy treatment – – Data will be featured in ...
The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate, as a perioperative neoadjuvant treatment and postcystectomy ...
Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...
-At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapy- -These unprecedented results support its ...
-lidERA is the second positive Phase III readout for giredestrant following evERA presented at ESMO 2025- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ...
NASHVILLE, Tenn. (WSMV) - Experts are warning about a concerning trend in breast cancer diagnoses, as cases of lobular breast cancer are rising three times faster than all other types of breast cancer ...
Authors say that because survival after seven years is lower, more early detection strategies are needed. HealthDay News — The incidence rates for invasive lobular carcinoma (ILC) increased from 2012 ...
SHREVEPORT, La. -- As Breast Cancer Awareness Month comes to a close, there’s encouraging news that more Americans are surviving cancer overall. But experts say there’s still much to learn—especially ...
Just weeks after learning she was expecting her fourth child, Stephanie Wysaski felt a lump on her chest. Tests confirmed that she had a breast cancer called invasive lobular carcinoma, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback